Tranexamic acid for severe gastrointestinal bleeding
Open Access
- 1 June 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 395 (10241), 1885-1886
- https://doi.org/10.1016/s0140-6736(20)30975-2
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trialThe Lancet, 2020
- Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus GroupAnnals of Internal Medicine, 2019
- Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trialThe Lancet, 2017
- Tranexamic Acid in Patients Undergoing Coronary-Artery SurgeryThe New England Journal of Medicine, 2017
- Challenges in the management of acute peptic ulcer bleedingThe Lancet, 2013
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trialThe Lancet, 2010
- Clinical practice and evidence in endoscopic treatment of bleeding peptic gastroduodenal ulcerScandinavian Journal of Gastroenterology, 2007